BILLS-107hr4832ih.pdf
House Resolutions
0 pages
Page
of 0
Loading OCR text...
No OCR text available for this page.
Failed to load OCR text.
DATE (6)
4832 IH
1396
fiscal year 2003
fiscal years
MAY 23, 2002
2002
EVENT (2)
SESSION
H. R. 4832
the ‘‘Prescription Drug
GPE (2)
Ohio
the United States of America
ORG (17)
Congress
THE HOUSE OF REPRESENTATIVES
the Agency for Healthcare Research and Quality
U.S.C.
Medicare
medicaid
Healthcare Research and Quality
House of Representa-
INDIVIDUALS ELIGIBLE
Healthcare
SEC
Senate
Agency
the Committee on Energy and Commerce
PERSON (10)
RANGEL
WAXMAN
KAPTUR
ALLEN
BROWN
LANGEVIN
DELAURO
BALDACCI
STARK
BERRY
Topic Classifications
congressional legislation
96.2%
government oversight
71.4%
public health
67.3%
Extracted Keywords
prescription drugs
prescription
drugs
effectiveness
medicare medicaid
medicaid
studies
analyses
expenditures
medicare
covered
director
levels
quality
research
Forensic Analysis
PDF Metadata
- ModDate
- D:20230115115253Z
- Producer
- Acrobat Distiller 4.0 for Windows; modified using iText® Core 7.2.3 (production version) ©2000-2022 iText Group NV, Government Publishing Office
- CreationDate
- D:20020527194345Z
Sentiment
Polarity
Neutral
0.017
Subjectivity
41%
Objective